159 related articles for article (PubMed ID: 2417306)
1. Prostate specific acid phosphatase versus five other possible tumour markers: a comparative study in men with prostatic carcinoma.
Larson A; Fritjofsson A; Norlén BJ; Gronowitz JS; Ronquist G
Scand J Clin Lab Invest Suppl; 1985; 179():81-8. PubMed ID: 2417306
[No Abstract] [Full Text] [Related]
2. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
[No Abstract] [Full Text] [Related]
3. [New prospective diagnostic serum markers in prostatic cancer].
Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
[No Abstract] [Full Text] [Related]
4. Tumour markers in monitoring the treatment of advanced prostate cancer.
Cooper EH; Armitage TG
Prog Clin Biol Res; 1990; 359():65-72; discussion 73-4. PubMed ID: 1704634
[No Abstract] [Full Text] [Related]
5. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
Morote Robles J; de Torres Mateos JA; Soler-Roselló A
Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
[No Abstract] [Full Text] [Related]
6. Serum levels of prostatic acid phosphatase (PAP), tissue polypeptide antigen (TPA), CA-50, neopterine and of osteocalcin in patients with prostatic carcinoma.
Lewenhaupt A; Ekman P; Eneroth P; Eriksson A; Nordström L
Scand J Clin Lab Invest Suppl; 1985; 179():75-80. PubMed ID: 3878574
[No Abstract] [Full Text] [Related]
7. Laboratory studies for the detection of carcinoma of the prostate.
Brawer MK
Urol Clin North Am; 1990 Nov; 17(4):759-68. PubMed ID: 1699341
[TBL] [Abstract][Full Text] [Related]
8. Serum prostatic acid phosphatase activity and prostate specific antigen when the prostate gland is enlarged.
Jenkins D; Jones RT; Clarke AM
Med Lab Sci; 1991 Apr; 48(2):161-3. PubMed ID: 1719330
[TBL] [Abstract][Full Text] [Related]
9. Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.
Tarle M
Anticancer Res; 1988; 8(4):569-72. PubMed ID: 2460018
[TBL] [Abstract][Full Text] [Related]
10. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
11. Immunologic markers and the diagnosis of prostatic cancer.
Ban Y; Wang MC; Chu TM
Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
[TBL] [Abstract][Full Text] [Related]
12. What clinical information is wanted from measurements of tumor markers in carcinoma of the prostate?
Andersson L
Scand J Clin Lab Invest Suppl; 1985; 179():107-14. PubMed ID: 3866303
[No Abstract] [Full Text] [Related]
13. [Clinical significance of tumor markers in prostatic carcinoma--comparative study of prostatic acid phosphatase, prostate specific antigen and gamma-seminoprotein].
Yoshiki T; Okada K; Oishi K; Yoshida O
Hinyokika Kiyo; 1987 Dec; 33(12):2044-9. PubMed ID: 2452559
[TBL] [Abstract][Full Text] [Related]
14. [A case of mucinous adenocarcinoma of the prostate].
Ezura M; Kimura N; Nagura H
Gan No Rinsho; 1990 Mar; 36(4):563-6. PubMed ID: 1690826
[TBL] [Abstract][Full Text] [Related]
15. Relative reliability of five serially measured markers for prognosis of progression in prostate cancer.
Killian CS; Emrich LJ; Vargas FP; Yang N; Wang MC; Priore RL; Murphy GP; Chu TM
J Natl Cancer Inst; 1986 Feb; 76(2):179-85. PubMed ID: 2418245
[TBL] [Abstract][Full Text] [Related]
16. Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
Kuriyama M; Wang MC; Lee CL; Killian CS; Papsidero LD; Inaji H; Loor RM; Lin MF; Nishiura T; Slack NH; Murphy GP; Chu TM
J Natl Cancer Inst; 1982 Jan; 68(1):99-105. PubMed ID: 6172628
[TBL] [Abstract][Full Text] [Related]
17. [Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer].
Bauer HW
Med Welt; 1982 Nov; 33(46):1616-21. PubMed ID: 6185820
[No Abstract] [Full Text] [Related]
18. [Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate].
Cooper EH; Bauer HW; Dati F
Ric Clin Lab; 1984; 14 Suppl 2():39-55. PubMed ID: 6085183
[No Abstract] [Full Text] [Related]
19. Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
Med Lett Drugs Ther; 1979 Nov; 21(22):90-1. PubMed ID: 492069
[No Abstract] [Full Text] [Related]
20. Screening for adenocarcinoma of the prostate.
Miles BJ
Henry Ford Hosp Med J; 1989; 37(1):5-7. PubMed ID: 2475458
[No Abstract] [Full Text] [Related]
[Next] [New Search]